These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 16881431

  • 81. The influence of sodium profiling on blood volume and intradialytic hypotension in patients on maintenance hemodialysis.
    Kaczmarczyk I, Kraśniak A, Drozdz M, Chowaniec E, Gajda M, Radziszewski A, Sułowicz W.
    Przegl Lek; 2007; 64(7-8):476-82. PubMed ID: 18409348
    [Abstract] [Full Text] [Related]

  • 82. Evaluation and Development of Vancomycin Dosing Schemes to Meet New AUC/MIC Targets in Intermittent Hemodialysis Using Monte Carlo Simulation Techniques.
    Lewis SJ, Mueller BA.
    J Clin Pharmacol; 2021 Feb; 61(2):211-223. PubMed ID: 32851685
    [Abstract] [Full Text] [Related]

  • 83. Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration.
    Burkhardt O, Kumar V, Katterwe D, Majcher-Peszynska J, Drewelow B, Derendorf H, Welte T.
    J Antimicrob Chemother; 2007 Feb; 59(2):277-84. PubMed ID: 17185298
    [Abstract] [Full Text] [Related]

  • 84. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
    Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL.
    Clin Infect Dis; 2009 Aug 15; 49(4):507-14. PubMed ID: 19586413
    [Abstract] [Full Text] [Related]

  • 85. Population pharmacokinetic analysis of vancomycin in patients with gram-positive infections and the influence of infectious disease type.
    Yamamoto M, Kuzuya T, Baba H, Yamada K, Nabeshima T.
    J Clin Pharm Ther; 2009 Aug 15; 34(4):473-83. PubMed ID: 19583681
    [Abstract] [Full Text] [Related]

  • 86.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 87. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
    Santoro A, Mancini E, Bolzani R, Boggi R, Cagnoli L, Francioso A, Fusaroli M, Piazza V, Rapanà R, Strippoli GF.
    Am J Kidney Dis; 2008 Sep 15; 52(3):507-18. PubMed ID: 18617304
    [Abstract] [Full Text] [Related]

  • 88.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 89.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 90. Vancomycin during the Last Hour of the Hemodialysis Session: A Pharmacokinetic Analysis.
    Ghouti-Terki L, Chasseuil E, Rabot N, Paintaud G, François M, Birmelé B, Darrouzain F, Büchler M, Halimi JM, Ternant D.
    Nephron; 2017 Sep 15; 135(4):261-267. PubMed ID: 28152540
    [Abstract] [Full Text] [Related]

  • 91.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 92.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 93. Dependence of vancomycin clearance on renal function via regression and bootstrap methods.
    Zellner D, Zellner GE, Keller F.
    J Clin Pharm Ther; 1998 Apr 15; 23(2):107-13. PubMed ID: 9786096
    [Abstract] [Full Text] [Related]

  • 94.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 95.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 96. Economic benefit of appropriate timing of vancomycin prophylaxis in patients undergoing cardiovascular surgery.
    Garey KW, Amrutkar P, Dao-Tran TK, Frost CP, Chen H, Essien EJ, Gentry LO.
    Pharmacotherapy; 2008 Jun 15; 28(6):699-706. PubMed ID: 18503397
    [Abstract] [Full Text] [Related]

  • 97.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 98.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 99.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 100.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.